Publications by authors named "Peter D Davis"

Claim this Profile
H
Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs.
Peter Thomson, Matthew A Naylor, Michael R L Stratford, Gemma Lewis, Sally Hill, Peter D Davis

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4.
Peter Thomson, Matthew A Naylor, Steven A Everett, Michael R L Stratford, Gemma Lewis, Peter D Davis

Mol Cancer Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
Gregory M Hayes, Shona T Dougherty, Peter D Davis, Graeme J Dougherty

Cancer Gene Ther· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular-targeted cancer gene therapy.
Graeme J Dougherty, Peter D Davis, Shona T Dougherty

Expert Opin Biol Ther· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting the differential production of angiogenic factors within the tumor microenvironment in the design of a novel vascular-targeted gene therapy-based approach to the treatment of cancer.
Carmine Carpenito, Peter D Davis, Shona T Dougherty, Graeme J Dougherty

Int J Radiat Oncol Biol Phys· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of vascular targeting by inhibitors of nitric oxide synthase.
Peter D Davis, Gillian M Tozer, Matthew A Naylor, Peter Thomson, Gemma Lewis

Int J Radiat Oncol Biol Phys· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Peter D Davis, Graeme J Dougherty, David C Blakey, Susan M Galbraith, Gillian M Tozer

Cancer Res· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.
David C Blakey, F Russell Westwood, Mike Walker, Gareth D Hughes, Peter D Davis

Clin Cancer Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative splicing as a novel of means of regulating the expression of therapeutic genes.
Gregory M Hayes, Carmine Carpenito, Peter D Davis, Shona T Dougherty, Julie F Dirks

Cancer Gene Ther· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis